Department of Commerce Announces Section 232 Pharmaceutical Investigation
By EsqSocial Corporation 17/04/25
The Trump Administration issued a notice on Monday titled, “Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients,” which could serve as a precursor to imposing tariffs on the pharmaceuticals sector. Under Section 232 of the Trade Expansion Act of 1962 (Section 232), the President may impose restrictions on certain imports if the Department of Commerce (DOC) determines that those restrictions are...
By: DLA Piper